Voxel suffered slump in medical systems sales in 2016 but expects better 2017
…ties, and the product offer has been or is being expanded to include unique solutions for oncology diagnostics, tele-histopathology solutions or pharmacy systems. There is also the prospect of increased EU funds inflows, which will help drive diagnostic equipment purchases, Voxel CEO said.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)